First floor
-
INPS. New service "THINK ME" (PENSione A MIsura), to know the future pension
In linea con la trasformazione digitale in atto, orientata verso servizi semplici, proattivi e sempre più vicini al cittadino, l’Inps…
Leggi » -
The case of the nurse who appropriates samples of free medicines: convicted of embezzlement
I campioni gratuiti di un farmaco: perchè non si possono prendere e portar via, visto che sono gratuiti? Se è…
Leggi » -
Magrini (AIFA). Two new vaccines available from the beginning of 2022: Novavax and Valneva
È attesa la valutazione di questa settimana da parte di Ema per Novbavax e poi a breve per Valneva. Nei primi…
Leggi » -
Dompè. Due to pandemic 11 ISF agents with VAT number at home
We are informed that 11 ISF single-mandate agents with VAT number of Dompè have had their agency mandate terminated,…
Leggi » -
Smart working. Agreement between Government and social partners on the new rules
The shared protocol for smart working The protocol shared between the ministry, employers' organizations and trade unions starts from the assumption…
Leggi » -
OO.SS press release and MSW Gedeon Richter. Four layoffs for a "flash reorganization". Bewilderment for the method and for the merit
Gedeon Richter's RSU learned today with bewilderment, from the company management, the intention to implement a reorganization…
Leggi » -
OO.SS press release Novartis unilaterally fires two whistleblowers. Unacceptable!
In data odierna NOVARTIS FARMA ha comunicato alle OO.SS. ed alle RSU la decisione di licenziare unilateralmente due informatori, motivando…
Leggi » -
Recanati doctor: "No-vax patients choose another doctor". Accused of "conniving with Big Pharma"
Amedeo Giorgetti, family doctor in Recanati, ended up in the media limelight for inviting no-vax patients with a sign…
Leggi » -
Covid vaccine, the Science study comparing Pfizer, Moderna and Johnson & Johnson protection in the USA
The data analysis has photographed a situation of substantially equal efficacy between the three compounds to prevent the infection of Sars…
Leggi » -
BioNtech's anticancer "vaccine" within 5 years
The immuno-oncologists who co-founded BioNTech, the company that developed…
Leggi »